New bone putty shows promise in spinal fusion trial
NCT ID NCT02466048
First seen Apr 29, 2026 · Last updated Jun 23, 2026 · Updated 9 times
Summary
This study tested a bone grafting material called SurgiFill™ in 20 adults undergoing spinal fusion surgery. The goal was to see if adding SurgiFill™ to the patient's own bone helped the vertebrae fuse better. Researchers compared bone healing on CT scans and X-rays over 12 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL FUSION ACQUIRED are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Catholic Univ. of Korea, Daejeon St. Mary's Hospital
Daejeon, Daejeon, 301723, South Korea
-
The Catholic Univ. of Korea, Seoul St. Mary's Hospital
Seoul, Seoul, 137701, South Korea
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SurgiFill™ (bone grafting material)
What this could lead to
If successful, SurgiFill™ could improve bone healing and fusion success in spinal surgery, potentially reducing the need for additional bone grafts.
What could go wrong
This is a small, early-stage trial with only 20 participants, so results may not apply widely. The material may not significantly improve fusion or could cause side effects like allergic reactions.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.